Skip to main content

Statistical Power and Bayesian Assurance in Clinical Trial Design

  • Chapter
  • First Online:
New Frontiers of Biostatistics and Bioinformatics

Part of the book series: ICSA Book Series in Statistics ((ICSABSS))

  • 1131 Accesses

Abstract

In clinical trial design, statistical power is defined as the probability of rejecting the null hypothesis at a pre-specified true clinical treatment effect, which is conditioned on the true but actually unknown effect. In practice, however, this true effect is never a fixed value, but a range from previously held trials which would lead to underpowered or overpowered trials. In order to incorporate the uncertainties of this observed treatment effect, a Bayesian assurance has been proposed as an alternative to the conventional statistical power. This is defined as the unconditional probability of rejecting the null hypothesis. In this chapter, we will review the transition from conventional statistical power to Bayesian assurance and discuss the computations of Bayesian assurance using a Monte-Carlo simulation-based approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Chen, D. G., & Ho, S. (2017). From statistical power to statistical assurance: It’s time for a paradigm change in clinical trial design. Communications in Statistics - Simulation and Computation., 46(10), 7957–7971.

    Article  MathSciNet  Google Scholar 

  • Chen, D. G., Peace, K. E., & Zhang, P. (2017). Clinical trial data analysis using R and SAS. Boca Raton, FL: Chapman & Hall/CRC Biostatistics Series.

    Google Scholar 

  • Chuang-Stein, C. (2006). Sample size and the probability of a successful trial. Pharmaceutical Statistics, 5, 305–309.

    Article  Google Scholar 

  • O’Hagan, A., & Stevens, J. W. (2001). Bayesian assessment of sample size for clinical trials of cost-effectiveness. Medical Decision Making, 21, 219–230.

    Article  Google Scholar 

  • O’Hagan, A., Stevens, J. W., & Campbell, M. (2005). Assurance in clinical trial design. Pharmaceutical Statistics, 4, 187–201.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ding-Geng Chen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chen, DG., Chen, J.K. (2018). Statistical Power and Bayesian Assurance in Clinical Trial Design. In: Zhao, Y., Chen, DG. (eds) New Frontiers of Biostatistics and Bioinformatics. ICSA Book Series in Statistics. Springer, Cham. https://doi.org/10.1007/978-3-319-99389-8_9

Download citation

Publish with us

Policies and ethics